Pulmonary arterial hypertension (PAH), the 1st group of pulmonary hypertension, is certainly a chronic and intensifying disorder characterised by angioproliferative vasculopathy in the pulmonary arterioles, resulting in endothelial and soft muscle dysfunction and proliferation, thrombosis and inflammation. with significant mortality and morbidity. Therefore, further study into broadening our knowledge of PAH pathophysiology can be underway… Continue reading Pulmonary arterial hypertension (PAH), the 1st group of pulmonary hypertension, is